Clinical Trial Update: A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for KHK7791 in hyperphosphatemia patients on hemodialysis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• KHK7791

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Hyperphosphatemia | Phase 2 | Status: COMPLETED